No substantial excess all-cause mortality among cardiac implantable electronic device patients during the first COVID‑19 lockdown in the Leiden area

Author:

Feijen M.ORCID,Egorova A. D.,van der Velde E. T.,Schalij M. J.,Beeres S. L. M. A.

Abstract

AbstractIn the Netherlands, the coronavirus disease 2019 (COVID‑19) pandemic has resulted in excess mortality nationwide. Chronic heart disease patients are at risk for a complicated COVID‑19 course. The current study investigates all-cause mortality among cardiac implantable electronic device (CIED) patients during the first peak of the pandemic and compares the data to the statistics for the corresponding period in the two previous years. Data of adult CIED patients undergoing follow-up at the Leiden University Medical Centre were analysed. All-cause mortality between 1 March and 31 May 2020 was evaluated and compared to the data for the same period in 2019 and 2018. At the beginning of the first peak of the pandemic, 3,171 CIED patients (median age 70 years; 68% male; 41% ischaemic aetiology) were alive. Baseline characteristics of the 2019 (n = 3,216) and 2018 (n = 3,169) cohorts were comparable. All-cause mortality during the peak of the pandemic was 1.4% compared to 1.6% and 1.4% in the same period in 2019 and 2018, respectively (p = 0.84). During the first peak of the COVID‑19 pandemic, there was no substantial excess mortality among CIED patients in the Leiden area, despite the fact that this is group at high risk for a complicated course of a COVID‑19 infection. Strict adherence to the preventive measures may have prevented substantial excess mortality in these vulnerable patients.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. National Institute for Public Health and the Environment, Ministry of Health Welfare and Sport. In-depth information about the novel coronavirus. 2020. https://www.rivm.nl/en/novel-coronavirus-covid-19/in-depth-information. Accessed: 22-07-2021.

2. National Institute for Public Health and the Environment, Ministry of Health Welfare and Sport. Risk groups and COVID‑19. 2020. https://www.rivm.nl/en/novel-coronavirus-covid-19/risk-groups. Accessed: 22-07-2021.

3. Statistics Netherlands. Mortality in times of corona: statistics Netherlands. 2020. https://www.cbs.nl/en-gb/news/2020/22/mortality-in-times-of-corona. Accessed: 22-07-2021.

4. de Koning ER, Boogers MJ, Bosch J, et al. Emergency medical services evaluations for chest pain during first COVID‑19 lockdown in Hollands-Midden, the Netherlands. Neth Heart J. 2021; https://doi.org/10.1007/s12471-021-01545-y.

5. Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID‑19 pandemic. J Am Coll Cardiol. 2020;75(22):2871–2.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3